Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia–Associated Epistaxis-Reference-Cited by-同舟云学术

Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia–Associated Epistaxis

Published:2020-11-01 Issue:11 Volume:146 Page:1006
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Peterson Andrew M.¹²,Lee Jake J.¹,Kallogjeri Dorina¹,Schneider John S.³,Chakinala Murali M.⁴⁵,Piccirillo Jay F.¹

Affiliation:

1. Clinical Outcomes Research Office, Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri

2. University of Missouri–Kansas City School of Medicine, Kansas City

3. Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri

4. Division of Pulmonary & Critical Care Medicine, Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri

5. Washington University Hereditary Hemorrhagic Telangiectasia Center of Excellence, St Louis, Missouri

Publisher

American Medical Association (AMA)

Subject

Otorhinolaryngology,Surgery

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2770784/jamaotolaryngology_peterson_2020_oi_200047_1605715042.45875.pdf

Reference24 articles.

1. The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.;Grosse;Genet Med,2014

2. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).;Zarrabeitia;Health Qual Life Outcomes,2017

3. Effect of topical intranasal therapy on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia: a randomized clinical trial.;Whitehead;JAMA,2016

4. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia—a preliminary report.;Mei-Zahav;J Otolaryngol Head Neck Surg,2017

5. Sclerotherapy and topical nasal propranolol: an effective and safe therapy for HHT-epistaxis.;Esteban-Casado;Laryngoscope,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary hemorrhagic telangiectasia (Osler’s disease): systemic, interdisciplinary, relatively common—and often missed;Deutsches Ärzteblatt international;2024-09-06

2. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management—Exploring the otolaryngologist's integral role;Auris Nasus Larynx;2024-04

3. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances;Journal of Clinical Investigation;2024-02-15

4. Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis;Current Allergy and Asthma Reports;2023-11-23

5. Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review;American Journal of Rhinology & Allergy;2023-10-19